Lunasin functionally enhances LDL uptake via inhibiting PCSK9 and enhancing LDLR expression in vitro and in vivo

Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a serine protease which regulates serum low-density lipoprotein cholesterol (LDL-C) levels by promoting the degradation of the hepatic low-density lipoprotein receptor (LDLR), and has become an attractive therapeutic target for cholesterol low...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Lili, Wang, Yue, Xu, Yaqiong, Tian, Qinghua, Lei, Gaoxin, Zhao, Cheng, Gao, Zhan, Pan, Qin, Zhao, Wenfeng, Nong, Liu, Tan, Shuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655242/
https://www.ncbi.nlm.nih.gov/pubmed/29113347
http://dx.doi.org/10.18632/oncotarget.20590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655242/
https://www.ncbi.nlm.nih.gov/pubmed/29113347
http://dx.doi.org/10.18632/oncotarget.20590

Ejemplares similares